<VariationArchive VariationID="1069384" VariationName="NM_031885.5(BBS2):c.1371del (p.Lys458fs)" VariationType="Deletion" Accession="VCV001069384" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1063680" VariationID="1069384">
      <GeneList>
        <Gene Symbol="BBS2" FullName="Bardet-Biedl syndrome 2" GeneID="583" HGNC_ID="HGNC:967" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="56470403" stop="56520024" display_start="56470403" display_stop="56520024" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="56518258" stop="56554007" display_start="56518258" display_stop="56554007" Strand="-" />
          </Location>
          <OMIM>606151</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_031885.5(BBS2):c.1371del (p.Lys458fs)</Name>
      <CanonicalSPDI>NC_000016.10:56500879:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="56500880" stop="56500880" display_start="56500880" display_stop="56500880" variantLength="1" positionVCF="56500879" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="56534792" stop="56534792" display_start="56534792" display_stop="56534792" variantLength="1" positionVCF="56534791" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>K458fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.56500880del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.56500880del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.56534792del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.56534792del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009312.2" sequenceAccession="NG_009312" sequenceVersion="2" change="g.24145del">
            <Expression>NG_009312.2:g.24145del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377456.1" sequenceAccession="NM_001377456" sequenceVersion="1" change="c.1371del">
            <Expression>NM_001377456.1:c.1371del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364385.1" sequenceAccession="NP_001364385" sequenceVersion="1" change="p.Lys458fs">
            <Expression>NP_001364385.1:p.Lys458fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031885.5" sequenceAccession="NM_031885" sequenceVersion="5" change="c.1371del" MANESelect="true">
            <Expression>NM_031885.5:c.1371del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_114091.4" sequenceAccession="NP_114091" sequenceVersion="4" change="p.Lys458fs">
            <Expression>NP_114091.4:p.Lys458fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165293.1" sequenceAccession="NR_165293" sequenceVersion="1" change="n.1533del">
            <Expression>NR_165293.1:n.1533del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165294.1" sequenceAccession="NR_165294" sequenceVersion="1" change="n.1533del">
            <Expression>NR_165294.1:n.1533del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031885.3" sequenceAccession="NM_031885" sequenceVersion="3" change="c.1371delG">
            <Expression>NM_031885.3:c.1371delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2144143132" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031885.5(BBS2):c.1371del (p.Lys458fs) AND Bardet-Biedl syndrome" Accession="RCV001381231" Version="7">
        <ClassifiedConditionList TraitSetID="6293">
          <ClassifiedCondition DB="MedGen" ID="C0752166">Bardet-Biedl syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-17" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031885.5(BBS2):c.1371del (p.Lys458fs) AND BBS2-related disorder" Accession="RCV004531192" Version="1">
        <ClassifiedConditionList TraitSetID="33575">
          <ClassifiedCondition DB="MedGen" ID="CN239228">BBS2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-17" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11285252</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20177705</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21052717</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24608809</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26518167</ID>
        </Citation>
        <DescriptionHistory Dated="2023-05-09">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="33575" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36425" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BBS2-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BBS2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">BBS2-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239228" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6293" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="376" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bardet-Biedl syndrome</ElementValue>
                <XRef ID="Bardet-Biedl+Syndrome/723" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015229" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS209900" DB="OMIM" />
                <XRef ID="5619004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BBS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6866" />
                <XRef ID="6866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301537</ID>
                <ID Source="BookShelf">NBK1363</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2010">
                <ID Source="pmc">3061994</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES/PES/ESE, 2017">
                <ID Source="PubMed">28359099</ID>
                <ID Source="pmc">6283429</ID>
              </Citation>
              <XRef ID="110" DB="Orphanet" />
              <XRef ID="C0752166" DB="MedGen" />
              <XRef ID="MONDO:0015229" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS209900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7333719" SubmissionDate="2023-04-14" DateLastUpdated="2023-05-13" DateCreated="2023-05-13">
        <ClinVarSubmissionID localKey="NM_031885.3:c.1371delG|MedGen:C0752166" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003923219" DateUpdated="2023-05-13" DateCreated="2023-05-13" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21052717</ID>
          </Citation>
          <Comment>Variant summary: BBS2 c.1371delG (p.Lys458ArgfsX29) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251458 control chromosomes (gnomAD). c.1371delG has been reported in the literature in an individual affected with Bardet-Biedl Syndrome (Janssen_2011). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted a clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BBS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_031885.3:c.1371delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0752166" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13077516</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7697696" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="30396007|BBS2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004120986" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The BBS2 c.1371delG variant is predicted to result in a frameshift and premature protein termination (p.Lys458Argfs*29). This variant was reported along with a second apparently disease-causing BBS2 variant in an individual with Bardet-Biedl syndrome (Janssen et al 2011. PubMed ID: 21052717). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in BBS2 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BBS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_031885.3:c.1371delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BBS2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3105144" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4931932|MedGen:C0752166" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579538" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11285252</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20177705</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24608809</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26518167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21052717</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in BBS2 are known to be pathogenic (PMID: 11285252, 20177705, 24608809, 26518167). This variant has been observed in individual(s) with clinical features of Bardet-Biedl syndrome (PMID: 21052717). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Lys458Argfs*29) in the BBS2 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BBS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.56534792del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0752166" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7333719" TraitType="Disease" MappingType="XRef" MappingValue="C0752166" MappingRef="MedGen">
        <MedGen CUI="C0752166" Name="Bardet-Biedl syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3105144" TraitType="Disease" MappingType="XRef" MappingValue="C0752166" MappingRef="MedGen">
        <MedGen CUI="C0752166" Name="Bardet-Biedl syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7697696" TraitType="Disease" MappingType="Name" MappingValue="BBS2-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239228" Name="BBS2-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

